Register for our free email digests:
Latest From Advanced Therapies Inc.
An EU Regulation intended to encourage research into advanced therapies by micro, small and medium-size enterprises (SMEs) has been published in the Official Journal and is expected to enter force next week.
The Italian government said that its reorganisation of AIFA, the national medicines regulatory agency, is nearly complete as a new board of directors was installed yesterday.
Independent researchers and researchers investigating advanced therapies in Spain should find it easier to gain approval for clinical trials thanks to a new support office, says the health ministry.
It's been a busy week for the European Medicines Agency. Not only has it recommended marketing approval of the first advanced therapy product under the new regulatory framework, it has also finally decided that all drugs containing the opioid painkiller dextropropoxyphene should be withdrawn for safety reasons.
- Drug Discovery Tools
- Large Molecule
- Therapeutic Areas
- Blood & Coagulation Disorders & Products
- Alchemia Pty. Ltd.
- Parent & Subsidiaries
- Alchemia Ltd.
- Senior Management
Jenni Pilcher Pilcher, CFO
Tracey Brown, PhD, CSO
Goslik Schepers, PhD, VP, Bus. Dev.
- Contact Info
Phone: (61) 7 3340 0200
3 Hi-Tech Court, Brisbane Tech. Park
8 Mile Plains
You must sign in to use this functionality
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.